A5102888581- Metabolism and Genetic Disorders
- Genetic Neurodegenerative Diseases
- Biomedical Research and Pathophysiology
- Neurological diseases and metabolism
- Parathyroid Disorders and Treatments
- Bone health and treatments
- Hereditary Neurological Disorders
- Mitochondrial Function and Pathology
- Diet and metabolism studies
- Liver Disease and Transplantation
- Neurological and metabolic disorders
- Potassium and Related Disorders
- Liver Disease Diagnosis and Treatment
- SARS-CoV-2 and COVID-19 Research
- Hemoglobinopathies and Related Disorders
- Hormonal Regulation and Hypertension
- Folate and B Vitamins Research
- Viral Infections and Vectors
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Erythrocyte Function and Pathophysiology
- Porphyrin Metabolism and Disorders
- Dermatological and Skeletal Disorders
- Adrenal Hormones and Disorders
- Heme Oxygenase-1 and Carbon Monoxide
Catholic University of Korea
2013-2021
Bucheon St. Mary's Hospital
2021
Korea National Institute of Health
2002-2003
National Institutes of Health
2001
A previously unknown SARS-CoV-2 vaccine protecting nonhuman primates from challenge was developed using RBD-P2 and N.
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that escape vaccine-induced neutralizing antibodies has indicated the importance T cell responses against this virus. In study, we highlight SARS-CoV-2 epitopes induce potent and discuss whether alone are adequate to confer protection describe administration 20 peptides with an RNA adjuvant in mice. have been synthesized based on spike nucleocapsid protein sequences. Our study demonstrates immunization...
Abstract We previously reported that mice immunized with recombinant modified vaccinia virus Ankara (MVA) encoding Japanese encephalitis (JEV) prM and E genes were completely protected against JEV challenge (Nam, J.H., Wyatt, L.S., Chae, S.L., Cho, H.W., Park, Y.K., Moss, B. Vaccine 1999, 17: 261–268). In this study, we examined the immunogenicity in swine of MVA (vJH9) or a DNA vaccine (pcJH‐1) expressing same genes. Although booster effect combination vJH9, pcJH‐1 inactivated commercial...